Dr. Sharon Jane Lin, MD

Dr. Lin practices at UCHealth Medical Group in Loveland, Colorado.

Dr. Lin's NPI, 1619362415, was assigned on March 30, 2015. Dr. Lin graduated from Cleveland Medical College, Homeopathic in 2015. Dr. Lin holds Colorado license DR.0069546.

Dr. Lin's primary practice is UCHealth Medical Group, at 2695 Rocky Mountain Ave, Loveland, CO 80538 in Larimer County. The practice phone is (970) 624-4443.

Dr. Lin's primary practice is UCHealth Medical Group in Loveland, Colorado. Dr. Lin is also affiliated with UCHealth Memorial Hospital Central. The medical group on file is UCHealth Medical Group. Dmand AI also links Dr. Lin to 3 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lin practices, 5 sites in all. Vendor and product names are available with a free account.

Otolaryngology is Dr. Lin's primary specialty in the NPI Registry, under taxonomy code 207Y00000X. Dr. Lin is board certified in otolaryngology by the American Board of Otolaryngology - Head and Neck Surgery. Dmand AI has Dr. Lin's licenses on file in 3 states: Colorado, Wisconsin and California.

Dmand AI lists acute sinusitis, ear eustachian tube disorders, ear infection, endoscopic sinus surgery, hearing loss and impairment, larynx and vocal cord disease, swimmer's ear and thyroid surgery among the conditions Dr. Lin treats.

CMS data shows 926 Medicare services from Dr. Lin across 13 procedure codes in 2024, for 312 Medicare patients. Medicare paid $63,157 for them. Every service was in an office.

CMS counts 312 Medicare patients who saw Dr. Lin in 2024. The largest group is 65 to 74, with 133 patients. 73% of them have high cholesterol, and 64% have high blood pressure. 12% are also on Medicaid. Their average risk score is 1.33, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Lin's median patient age at 70, with 57% women.

In 2024, Dr. Lin wrote 327 Medicare Part D claims for 130 patients. 91% of them were for generic drugs. CMS names the drug for 235 of them, across 11 drugs with 11 or more claims each, at $9,220 in total drug cost. In 2023, CMS named 109 claims across 6 drugs.

Dr. Lin accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 4 papers to Dr. Lin, published from 2016 to 2020. 2020 was the busiest year, with 2. Dr. Lin has published most often in Am J Otolaryngol. Dr. Lin's most frequent co-authors are Emily Niloufar Ahadizadeh, MD, Peter Charles Belafsky, MD, PhD and Arnaud F. Bewley, MD.

CMS Open Payments shows 22 general payments to Dr. Lin from 7 drug and device companies from 2021 to 2025. Food and beverage make up the largest share, 51% of the total. MED-EL Corporation paid the most, $1,328.

Dr. Lin graduated from Cleveland Medical College, Homeopathic in 2015.

Dr. Lin is in network with 17 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.